163 related articles for article (PubMed ID: 37358356)
21. Evaluating the effectiveness of abbreviated breast MRI (abMRI) interpretation training for mammogram readers: a multi-centre study assessing diagnostic performance, using an enriched dataset.
Jones LI; Marshall A; Elangovan P; Geach R; McKeown-Keegan S; Vinnicombe S; Harding SA; Taylor-Phillips S; Halling-Brown M; Foy C; O'Flynn E; Ghiasvand H; Hulme C; Dunn JA;
Breast Cancer Res; 2022 Jul; 24(1):55. PubMed ID: 35907862
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Taylor SA; Mallett S; Bhatnagar G; Morris S; Quinn L; Tomini F; Miles A; Baldwin-Cleland R; Bloom S; Gupta A; Hamlin PJ; Hart AL; Higginson A; Jacobs I; McCartney S; Murray CD; Plumb AA; Pollok RC; Rodriguez-Justo M; Shabir Z; Slater A; Tolan D; Travis S; Windsor A; Wylie P; Zealley I; Halligan S
Health Technol Assess; 2019 Aug; 23(42):1-162. PubMed ID: 31432777
[TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
24. Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
Chiabai O; Van Nieuwenhove S; Vekemans MC; Tombal B; Peeters F; Wuts J; Triqueneaux P; Omoumi P; Kirchgesner T; Michoux N; Lecouvet FE
Eur Radiol; 2023 Jan; 33(1):244-257. PubMed ID: 35925384
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis.
Wu LM; Gu HY; Zheng J; Xu X; Lin LH; Deng X; Zhang W; Xu JR
J Magn Reson Imaging; 2011 Jul; 34(1):128-35. PubMed ID: 21618333
[TBL] [Abstract][Full Text] [Related]
26. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
[No Abstract] [Full Text] [Related]
27. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
28. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
[TBL] [Abstract][Full Text] [Related]
30. Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
Metser U; Chan R; Veit-Haibach P; Ghai S; Tau N
AJR Am J Roentgenol; 2019 Feb; 212(2):377-381. PubMed ID: 30332285
[TBL] [Abstract][Full Text] [Related]
31. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?
Petralia G; Padhani A; Summers P; Alessi S; Raimondi S; Testori A; Bellomi M
Eur Radiol; 2013 Dec; 23(12):3466-76. PubMed ID: 23884300
[TBL] [Abstract][Full Text] [Related]
32. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
[TBL] [Abstract][Full Text] [Related]
33. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
[TBL] [Abstract][Full Text] [Related]
34. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Evans REC; Taylor SA; Kalasthry J; Sakai NS; Miles A;
Clin Radiol; 2020 Apr; 75(4):308-315. PubMed ID: 31836179
[TBL] [Abstract][Full Text] [Related]
35. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
Miles A; Taylor SA; Evans REC; Halligan S; Beare S; Bridgewater J; Goh V; Janes S; Navani N; Oliver A; Morton A; Rockall A; Clarke CS; Morris S;
Eur Radiol; 2019 Jul; 29(7):3889-3900. PubMed ID: 30937589
[TBL] [Abstract][Full Text] [Related]
36. Efficient whole-body MRI interpretation: evaluation of a dedicated software prototype.
Asbach P; Canda V; Hermann KG; Krug L; Hahn HK; Hamm B; Klessen C
J Digit Imaging; 2008 Oct; 21 Suppl 1(Suppl 1):S50-8. PubMed ID: 18266034
[TBL] [Abstract][Full Text] [Related]
37. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
Lecouvet FE; Pasoglou V; Van Nieuwenhove S; Van Haver T; de Broqueville Q; Denolin V; Triqueneaux P; Tombal B; Michoux N
Eur Radiol; 2020 Jun; 30(6):3083-3093. PubMed ID: 32065282
[TBL] [Abstract][Full Text] [Related]
38. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
[TBL] [Abstract][Full Text] [Related]
39. Detection of distant metastases in rectal cancer: contrast-enhanced CT vs whole body MRI.
Yoon JH; Yu MH; Hur BY; Park CM; Lee JM
Eur Radiol; 2021 Jan; 31(1):104-111. PubMed ID: 32789755
[TBL] [Abstract][Full Text] [Related]
40. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
